Venezuelan President Nicolas Maduro on Tuesday proposed administering a Russian coronavirus vaccine to nearly 15,000 candidates in upcoming legislative elections so that they can campaign safely.
Russia in August licensed a COVID-19 vaccine after less than two months of human testing, a move celebrated by Moscow but questioned by some experts who note that only about 10% of clinical trials are successful.
Maduro’s adversaries are broadly planning to boycott the Dec. 6 vote on the grounds that it is rigged in favor of the ruling Socialist Party, although one faction of the opposition has opened talks with the government to seek vote guarantees. “It would be a good idea to give the Russian vaccine to the 14,400 candidates who have registered ... so that they can carry out their electoral campaign more comfortably,” Maduro said during a televised address. He said that in September, some Russian vaccines would arrive for clinical trials, and that in October “other vaccines” would arrive, without elaborating. Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published on Friday by The Lancet medical journal, which noted that long-term trials were still necessary. Kirill Dmitriev of Russia’s sovereign wealth fund, which has backed the vaccine, said at least 3,000 people had already been recruited for the large-scale Sputnik-V trial, and that initial results were expected in October or November.Reporting by Brian Ellsworth; editing by Richard Pullin
Please follow us on Google to support usUnited States Latest News, United States Headlines
Similar News: You can also read news stories similar to this one that we have collected from other news sources.
Russia completes early trials of second potential COVID-19 vaccine: IfaxSiberia's Vector virology institute on Tuesday completed early-stage human trials, known as Phase II, of a second potential Russian vaccine against COVID-19, the state consumer safety watchdog was cited by the Interfax news agency as saying.
Read more »
COVID vaccine candidate developed by Oxford University and AstraZeneca put on hold after 'unexplained illness'Drug giant AstraZeneca is reviewing the event that caused the illness during Phase 3 of Oxford's COVID-19 vaccine trials. The interruption represents the first major hiccup in what has been a smooth path in the rapid vaccine effort spanning the globe.
Read more »
COVID-19 Vaccine Trial Paused, Due To Illness In One VolunteerDrugmaker AstraZeneca says it's pausing its COVID-19 vaccine trial because of a 'potentially unexplained illness' in one of the trial volunteers. A safety review will be conducted to determine if it's a chance event or somehow related to the vaccine.
Read more »
Trump's warp speed COVID vaccine plan hits snag as AstraZeneca pauses trialPhase 3 trials for AstraZeneca's COVID-19 vaccine candidate were paused Tuesday due to a 'potentially unexplained illness in one of the trials.'
Read more »